Bian Jin, Long Junyu, Yang Xu, Yang Xiaobo, Xu Yiyao, Lu Xin, Guan Mei, Sang Xinting, Zhao Haitao
Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Ann Transl Med. 2021 May;9(9):765. doi: 10.21037/atm-20-7101.
Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related deaths worldwide. Copy number variations (CNVs) affect the expression of genes and play critical roles in carcinogenesis. We aimed to identify specific CNV-driven genes and establish a prognostic model for HCC.
Integrative analysis of CNVs difference data and differentially expressed genes (DEGs) data from The Cancer Genome Atlas (TCGA) were conducted to identify critical CNV-driven genes for HCC. A risk model was constructed based on univariate Cox regression analysis, Least Absolute Shrinkage and Selection Operator (LASSO), and multivariate Cox regression analyses. The associations between CNV-driven genes signature and infiltrating immune cells were explored. The International Cancer Genome Consortium (ICGC) dataset was utilized to validate this model.
After integrative analysis of CNVs and corresponding mRNA expression profiles, 568 CNV-driven genes were identified. Sixty-three CNV-driven genes were found to be markedly associated with overall survival (OS) after univariate Cox regression analysis. Finally, eight CNV-driven genes were screened to generate a prognostic risk model. Compared with low-risk group, the OS of patients in the high-risk group was significantly shorter in both the TCGA [hazard ratio (HR) =6.14, 95% confidence interval (CI): 2.72-13.86, P<0.001] and ICGC (HR =3.23, 95% CI: 1.17-8.92, P<0.001) datasets. Further analysis revealed the infiltrating neutrophils were positively correlated with risk score. Meanwhile, the high-risk group was associated with higher expression of immune checkpoint genes.
A novel signature based on CNV-driven genes was built to predict the survival of HCC patients and showed good performance. The results of our study may improve understanding of the mechanism that drives HCC, and provide an immunological perspective for individualized therapies.
肝细胞癌(HCC)是全球癌症相关死亡的主要原因之一。拷贝数变异(CNV)影响基因表达并在致癌过程中起关键作用。我们旨在识别特定的CNV驱动基因并建立HCC的预后模型。
对来自癌症基因组图谱(TCGA)的CNV差异数据和差异表达基因(DEG)数据进行综合分析,以识别HCC的关键CNV驱动基因。基于单变量Cox回归分析、最小绝对收缩和选择算子(LASSO)以及多变量Cox回归分析构建风险模型。探索CNV驱动基因特征与浸润性免疫细胞之间的关联。利用国际癌症基因组联盟(ICGC)数据集验证该模型。
对CNV和相应的mRNA表达谱进行综合分析后,鉴定出568个CNV驱动基因。单变量Cox回归分析发现63个CNV驱动基因与总生存期(OS)显著相关。最后,筛选出8个CNV驱动基因以生成预后风险模型。与低风险组相比,高风险组患者在TCGA数据集[风险比(HR)=6.14,95%置信区间(CI):2.72 - 13.86,P<0.001]和ICGC数据集(HR =3.23,95% CI:1.17 - 8.92,P<0.001)中的OS均显著缩短。进一步分析显示浸润性中性粒细胞与风险评分呈正相关。同时,高风险组与免疫检查点基因的高表达相关。
建立了一种基于CNV驱动基因的新型特征来预测HCC患者的生存情况,且表现良好。我们的研究结果可能会增进对驱动HCC机制的理解,并为个体化治疗提供免疫学视角。